Early Survivorship Care Linked to Improved Outcomes in Head and Neck Cancer

Early integration of multidisciplinary survivorship care during radiotherapy was associated with improved treatment adherence, lower recurrence risk, and better disease-free survival among patients with head and neck cancer (HNC), according to a retrospective cohort study published in JAMA Otolaryngology–Head & Neck Surgery.^1,2

Among 471 patients treated with definitive, curative-intent radiotherapy, those who attended a multidisciplinary HNC survivorship clinic before completing radiotherapy had 55% lower odds of treatment nonadherence (OR, 0.45; 95% CI, 0.27-0.75), lower 3-year recurrence risk (subdistribution HR, 0.62; 95% CI, 0.40-0.94), and improved 3-year DFS (HR, 0.61; 95% CI, 0.41-0.91). These associations remained significant after adjustment for clinical and sociodemographic factors.

Study Design

The retrospective cohort study included patients with HNC who completed definitive, curative-intent radiotherapy at an academic center between March 21, 2018, and March 25, 2025. Patients treated with primary surgery or palliative-intent radiotherapy were excluded. Of the 471 patients, 148 (31.4%) received early survivorship care, and 247 (52.4%) adhered to radiotherapy.

Early survivorship care was defined as attendance at a multidisciplinary HNC survivorship clinic before radiotherapy completion. Analyses were adjusted for clinical and sociodemographic factors, including tumor and nodal categories, systemic therapy, insurance status, tobacco and alcohol use, and neighborhood-level socioeconomic disadvantage.

Limitations and Implications

The association between early survivorship care and clinical outcomes raises a question beyond whether patients receive supportive services: whether the timing of those services matters. Survivorship care is commonly emphasized after treatment, even though patients may need multidisciplinary support during active therapy. Integrating these services earlier could provide an opportunity to address barriers to treatment completion before radiotherapy ends.

“These findings suggest that earlier integration of multidisciplinary survivorship care, rather than solely after treatment, may be a modifiable care delivery strategy with potential relevance across cancer populations,” study authors Nilsen et al concluded.

Importantly, the association with survival outcomes was not explained solely by differences in radiotherapy adherence. This finding suggests that treatment completion may represent only one aspect of the relationship between early survivorship care and outcomes. However, the study did not establish which components of care contributed to the observed associations or whether particular patient needs were responsible for differences in outcomes.

The findings also raise questions about how survivorship services should be incorporated into treatment pathways. If earlier access contributes to better outcomes, referral timing and coordination with the treating oncology team may warrant closer evaluation. Determining which patients benefit most, what services are essential, and how early intervention affects resource utilization will be important for assessing the feasibility of broader implementation.

The retrospective design limits causal conclusions, as unmeasured differences between patients who attended the clinic and those who did not may have influenced the results. Additionally, the cohort came from a single academic center, limiting generalizability to other settings. The findings therefore support further evaluation of early survivorship care rather than establishing it as a proven strategy for improving survival.

Looking ahead, the investigators plan to evaluate how survivorship care timing affects health care utilization and costs. They also propose a randomized controlled trial to better isolate the effects of early survivorship care from other factors influencing treatment adherence and survival.

REFERENCES

1. Nilsen ML, Carlson KM, Owoc MS, et al. Survivorship Care Before Completion of Definitive Radiotherapy and Oncologic Outcomes in Head and Neck Cancer. JAMA Otolaryngology–Head & Neck Surgery. Published online October 22, 2026. doi:10.1001/jamaoto.2026.3198

2. Earlier Survivorship Care Linked to Lower Risk of Head and Neck Cancer. News release. UPMC. October 22, 2026. Accessed October 23, 2026. https://tinyurl.com/ms97da9f